As of 2026-09-10, the Relative Valuation of Albireo Pharma Inc (ALBO) is (112.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -355.6%.
The range of the Relative Valuation is (62.46) - (132.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 22.4x | 19.6x |
| Forward P/E multiples | 9.5x - 21.0x | 16.1x |
| Fair Price | (62.46) - (132.88) | (112.84) |
| Upside | -241.5% - -401.0% | -355.6% |
| Date | P/E |